Proton therapy for skull base tumors: A review of clinical outcomes for chordomas and chondrosarcomas.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 30537295.
- Also identified by DOI 10.1002/hed.25479.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Skull base chordomas and chondrosarcomas are rare tumors traditionally treated by surgical resection and adjuvant radiation therapy (RT). We will discuss data evaluating clinical outcomes of proton therapy in the treatment of skull base chordomas and chondrosarcomas. A literature review was performed using a MEDLINE search from January 1990 to January 2017. The published data suggest that the dose intensification allowed by proton therapy has resulted in good clinical outcomes and a tolerable toxicity profile. Proton therapy is a modern RT technique that has demonstrated improved preliminary clinical outcomes in the treatment of skull base chordomas and chondrosarcomas compared to conventional radiotherapy, and comparable to other advanced photon-based RT techniques.
Medical subject headings
- Chondrosarcoma
- Chordoma
- Proton Therapy
- Skull Base Neoplasms